As previously announced, ACELYRIN held an End of Phase 2 (EOP2) meeting with the United States Food and Drug Administration (FDA) in Q3 2024 and gained alignment on the proposed LONGITUDE-1 and ...
Introduction The American saying, which originated in the early 1970s postulates that: “if it isn’t broke don’t fix it” comes to mind every time I have ...